| WCN24-1778 CHRONIC KIDNEY DISEASE: A MODEL FOR ANALYZING GENDER INEQUITY IN ACCESS TO THE HEALTH CARE SYSTEM A Zinoveev, L Luzardo, P Ríos, A Ferreiro, CM Laura, L Gadola, ... Kidney International Reports 9 (4), S403, 2024 | | 2024 |
| WCN24-1029 PREVALENCE AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CARDIORENAL SYNDROME WITH REDUCED VENTRICULAR FUNCTION R Silvariño, F Bonanata, H Cabrera, J Castro, V Clouzet, L Perroni, ... Kidney International Reports 9 (4), S547-S548, 2024 | | 2024 |
| WCN24-2501 BODY MASS INDEX AND MORTALITY RISK IN A CHRONIC KIDNEY DISEASE 1-5ND COHORT A Ferreiro, P Rios, R Silvariño, J Santiago, L Solá, G Suarez, L Gadola Kidney International Reports 9 (4), S296, 2024 | | 2024 |
| WCN24-685 HISTOPATHOLOGICAL FINDINGS IN THE RENAL BIOPSY OF NATIVE KIDNEYS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2-DM) R Silvariño, V Sorondo, S San Román, C Baccino Kidney International Reports 9 (4), S139-S140, 2024 | | 2024 |
| WCN24-713 ONLINE HEMODIAFILTRATION IS MORE EFFICIENT THAN HIGH FLOW HEMODIALYSIS IN THE CLEARANCE OF MEDIUM WEIGHT MOLECULES RENDERING AS BETA 2 MICROGLOBULIN R Silvariño, F Brovetto, C Baccino, S San Román, O Noboa, S Lecueder Kidney International Reports 9 (4), S365-S366, 2024 | | 2024 |
| WCN24-1069 VALIDATION OF THE KIDNEY FAILURE RISK EQUATION (KFRE) AND ITS APPLICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE FOLLOWED BY THE RENAL HEALTH-CARE PROGRAM OF URUGUAY D González, L Sola, P Rios, L Gadola, J Santiago, R Silvariño, G Suárez, ... Kidney International Reports 9 (4), S86-S87, 2024 | | 2024 |
| WCN24-1352 IMPACT OF THE SARS-COV-2 PANDEMIC IN END-STAGE RENAL DISEASE PATIENTS IN LATIN AMERICA–MULTINATIONAL COLLABORATIVE GROUP OF THE SOUTHERN CONE L Toro, R Torres, A Vallejos, L Sola, R Silvariño Kidney International Reports 9 (4), S209, 2024 | | 2024 |
| WCN24-986 PLACEMENT OF PERITONEAL CATHETERS BY NEPHROLOGISTS: EXPERIENCE AT A UNIVERSITY PERITONEAL DIALYSIS CENTER R Silvariño, S San Román, C Baccino, A Noboa, J Boggia, O Noboa, ... Kidney International Reports 9 (4), S584-S585, 2024 | | 2024 |
| WCN24-895 RENAL HEAVY CHAIN AMYLOIDOSIS: AN EXCEPTIONAL VARIANT–A CASE REPORT R Silvariño, E Cabrera, L Peluffo, S San Román, C Baccino, S Acle, ... Kidney International Reports 9 (4), S146-S147, 2024 | | 2024 |
| Health policy for universal, sustainable and equitable kidney care R Silvariño, L Solá Nature Reviews Nephrology 20 (3), 147-148, 2024 | 1 | 2024 |
| Extended online hemodiafiltration associated with single-pass albumin dialysis, a feasible alternative for patients with hepatorenal insufficiency R Silvariño, S San Román, L Peluffo, A Opertti, G Grecco, O Noboa, ... Nefrología (English Edition) 43 (6), 801-803, 2023 | | 2023 |
| Hemodiafiltración en línea extendida asociada a diálisis con albúmina de paso simple, una alternativa factible para pacientes con insuficiencia hepatorrenal R Silvariño, S San Román, L Peluffo, A Opertti, G Grecco, O Noboa, ... nefrologia 43 (6), 801-803, 2023 | | 2023 |
| Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis LJ Appel, M Grams, M Woodward, K Harris, H Arima, J Chalmers, ... Jama 330 (13), 1266-1277, 2023 | 22 | 2023 |
| Mineral and bone disorder and longterm survival in a chronic kidney disease grade 3b-4cohort P Rios, R Silvariño, L Sola, A Ferreiro, V Lamadrid, L Fajardo, L Gadola Renal Failure 44 (1), 1357-1368, 2022 | 3 | 2022 |
| Adherence to multidisciplinary care in a prospective chronic kidney disease cohort is associated with better outcomes P Rios, L Sola, A Ferreiro, R Silvariño, V Lamadrid, L Ceretta, L Gadola, ... PLoS One 17 (10), e0266617, 2022 | 10 | 2022 |
| Autosomal dominant polycystic kidney disease. Who can benefit from tolvaptan therapy? State of the art R Silvariño, L Peluffo, E Cabrera, S San Román, C Baccino, O Noboa Revista Médica del Uruguay 38 (3), 2022 | | 2022 |
| Doença renal policística autossômica dominante: quem se beneficia do tratamento com tolvaptano? Estado da arte R Silvariño, L Peluffo, E Cabrera, S San Román, C Baccino, O Noboa Revista Médica del Uruguay 38 (3), 2022 | | 2022 |
| Medical specialists supply in Uruguay in 2020. A study that focuses on nephrologists. F Cavalleri, M Buglioli, R Silvariño, J Boggia Revista Médica del Uruguay 38 (3), 2022 | | 2022 |
| Poliquistosis renal autosómica dominante:¿ quiénes se benefician del tratamiento con tolvaptán?. Estado del arte R Silvariño, L Peluffo, E Cabrera, S San Román, C Baccino, O Noboa Revista Médica del Uruguay 38 (3), 2022 | | 2022 |
| Oferta de médicos especialistas no Uruguai, 2020. O caso da nefrologia F Cavalleri, M Buglioli, R Silvariño, J Boggia Revista Médica del Uruguay 38 (3), 2022 | 3 | 2022 |
Oscar NoboaDirector del Centro de Nefrología, Hospital de Clínicas, Universidad de la República在 hc.edu.uy 的电子邮件经过验证
